Documente Academic
Documente Profesional
Documente Cultură
TENSMED IV 4034
Tensmed
Content
User Manual
English
Revisao: 05
02 .............Presentation
02 .............Accessories supplied with the device
03 .............General Information
04 .............Symbols
05 .............Warnings
06 .............Electrical Installation / Connection
07 .............Using TENS as therapy
08 .............Operation modes
11 .............Using TENS for acute pain
12 .............Using TENS for chronic pain
14 .............Types of Electrodes
14 .............Electrode positioning
15 .............Electrode application
17 .............Tensmed II = Controls
19 .............Tensmed II = Control functions
20 .............Tensmed II = Unit operation
23 .............Tensmed IV = Controls
25 .............Tensmed IV = Control functions
26 .............Tensmed IV = Unit operation
29 .............Indications
30 .............Contraindications
30 .............Preventive maintenance and conservation
31 .............Precaution Instructions
31 .............Corrective maintenance
32 .............Technical data
34 .Acessories
34 .............Applicable Normas
40 .............Final considerations
41 .............References
43 .............General literature
MU_4034_4044_ENG_Rev05_092009
TENSMED II 4044
TENSMED IV 4034
TENSMED II 4044
TENSMED IV 4034
Presentation
General Information
What is Pain?
04 Electrode cables
01 Users Manual
TENSMED II 4052
02 Electrode cables
01 Users Manual
To buy optional accessories, please verify the codes at page 34,
Accessories .
If you have any doubt, please contact:
Technical Assistance Department
Rua lvares Fagundes, 359
So Paulo SP Brasil CEP 04338-000
Tel.: (0XX11) 5621-7024 / 5622-8205
e-mail : sat@carci.com.br
MU_4034_4044_ENG_Rev05_092009
MU_4034_4044_ENG_Rev05_092009
TENSMED II 4044
TENSMED IV 4034
Symbols
TENSMED II 4044
TENSMED IV 4034
Packaging symbols
Device symbols
Caution fragile. Handle with care
Device is off
IPX0
Device is on
Class II equipment
WARNINGS
1.
Manufacturer Identification
2.
Product Manufacture Date
3.
MU_4034_4044_ENG_Rev05_092009
MU_4034_4044_ENG_Rev05_092009
TENSMED II 4044
TENSMED IV 4034
6.
Electrical Installation/Connection
For a perfect device operation, we suggest electrical installations according
to the following rules:
Brazil:
NBR 5410/1990 Low-voltage electrical installations;
NBR13534/1995 Electrical installations at medical locations Safety requirements.
Other Countries:
IEC 60364-7-7 (10/2002) Electrical Installations medical
locations;
Or another related norm applicable in the utilization country.
TENSMED II 4044
TENSMED IV 4034
Connect one end of the power cable to the connector on the rear panel
and one end to the power supply outlet
Action
S
ISTEMA
System
DE
AO
NervousNERVOS
FibersAS
FIBRRAS
Type
TIPOIIIIand
E IIIIII
Gelatin
SUBS
TNCIA
Substance
GELAT
INOSA
Nervous
FibersAS
FIBRRAS
NERVOS
Type
IV
TIPO IV
Figure 01.
Your equipment can operate with any voltage between 100 and
230VAC, 50 or 60Hz.
In case of blown fuse, change it for another protection fuse of the same
value, as indicated:
MU_4034_4044_ENG_Rev05_092009
Transmission
CLULA
Cell SORA
TRNAMIS
(Laminae
(LAMINAV)
V)
Gate
Control
System
SISTEMA
DE CONT
ROLE
DA PORTA
This theory is based on the association that stimuli from thick myelinated
nervers produce a marrow-level inhibition. This inhibition blocks the pain
stimulus transmission to the brain, conveyed by thin unmyelinated nerves.
MU_4034_4044_ENG_Rev05_092009
TENSMED II 4044
TENSMED IV 4034
In other words, through a selective stimulus of nerves Type II and III, the
stimulus transmission is inhibited by nerves Type IV. Stimulus of nerves
Type IV is not desirable in this process.
This theory shows one of the main starting points for the pain treatment.
Category Efferent
Thick
Thin
A
A
A
A
B
C
Afferent
I
II
III
III
IV
Speed
M/s
70 120
50 70
30 50
< 30
3 14
<3
Diameter
m
12 22
5 12
5 12
25
13
0.1 1.3
TENSMED II 4044
TENSMED IV 4034
CONTINUOUS
In this operation mode, the unit outputs a continuous frequency signal and
variable pulse duration.
The frequency value setting range is 1Hz to 200Hz, being: from 1Hz to
10Hz in 1Hz steps; from 10Hz to 50 Hz in 5 Hz steps; and from 50 Hz
to 200 Hz in 10 Hz steps).
I
T
Continuous
Mode
Modo Contnuo
The chronic pain always comes with the patients endorphin system
hypoactivity or increased consumption of released endorphins. The
utilization of pulse trains of TENS allows to stimulate the central nervous
system, in such way to provoke the release of endogen substances, thus
obtaining an analgesic effect as a result.
According to Sjolund and Eriksson, endorphins are released if we apply
low-frequency modulated (interrupted) 100Hz frequency, usually between 2
Hz and 5 Hz (in BURST mode).
BURST
In this operation mode, the unit outputs a continuous signal modulated by a
2Hz frequency.
The output frequency is fixed at 100Hz and modulated (interrupted) by
a 2Hz frequency.
The pulse duration setting range is 50 s to 400 s, in 10 s steps.
The figure below illustrates the BURST mode:
Operation modes
0
Modo Burst
Burst Mode
Burst
Burst
Mode
Mode
MU_4034_4044_ENG_Rev05_092009
MU_4034_4044_ENG_Rev05_092009
TENSMED II 4044
TENSMED IV 4034
TENSMED II 4044
TENSMED IV 4034
VIF
VLF
In this operation mode, the unit outputs a signal of Frequency and Pulse
Width automatic variation. That is, the adjusted frequency and pulse width
values present a +25% variation in a 3 second period, returning to the
original value, and a 25% variation in a 3 second period, returning to the
original value. This cycle is indefinitely repeated.
The frequency setting value is 5Hz to 170Hz, being: from 5Hz to 10Hz in
1Hz steps; from 10Hz to 50 Hz in 5 Hz steps; and from 50 Hz to 170 Hz
in 10 Hz steps).
The pulse width setting value is 70 s to 370 s, in 10 s steps.
0
VIF Mode
VIF Mode
Modo
VIF
VLP
In this operation mode, the unit outputs a signal of pulse width automatic
variation. That is, the adjusted pulse width value presents a +25% variation
in a 3 second period, returning to the original value, and a 25% variation
in a 3 second period, returning to the original value. This cycle is indefinitely
repeated.
The frequency is fixed, according to the selected value, which can be set
between 1Hz and 200Hz.
The pulse duration presents a variation of + / - 25% of the selected
value, which can be set between 70 s and 370 s.
MU_4034_4044_ENG_Rev05_092009
10
Electrode
Placement
Pulse
Pulse
Intensity
Duration Frequency
Treatment
Frequency
***********
*******
********
********
Hz
ref. 15
after
laparotomy
parallel to
incision
120-340
10-100
ref. 16
after
laparotomy
parallel to
incision
80
40
ref. 18
after
laparotomy
parallel to
incision
128-200
10-100
ref. 17
after
surgery
parallel to
incision
**********
**********
MU_4034_4044_ENG_Rev05_092009
*******
0-90 V
Constant in
Comfortable first 48 hours
Comfortable
60 min. each
4 hours
0-135 mA
Constant in
Comfortable first 48 hours
*******
Constant in
first 48 hours
11
TENSMED II 4044
TENSMED IV 4034
ref. 19
after
above and
Caesarian
below incision
section
ref. 20
delivery
pain
ref. 21
delivery
pain
ref. 5
paraesp.
T10-L1,S2-S4
**********
250-400
**********
**********
200
80-100
**********
**********
100
20-35 mA
Constant or 30
min. 4 times a
day
st
20-25 V
Comfortable
During 1
stage of
delivery
Comfortable
During 1st
stage of
delivery
2-3 X
sensor level
30 min.
MU_4034_4044_ENG_Rev05_092009
12
TENSMED II 4044
TENSMED IV 4034
Twelve days after the application:
Author
Diagnosis
*******
**********
***********
Hz
********
***********
ref.13
Varied
beside the
painful region
100
50-100
sub-motor
level
30-45 min.
3-5 times a
week
ref.14
Varied
Varied
mid scale
10-100
comfortable
30-60 min. a
day
ref.22
column pain
ref.23
backache
backache
central part
ref.24
knee
osteoarthritis
on knees
ref.25
phantom limb
pain
ref.26
ref.27
paravertebral maximum
************
2/abr
4/ago
30 min. 2 x
a week
30-60 min.
a day
stump or
central limb
************
15 min. 2 x
a day
fracture
on fracture
300
Neuro-peripheral
pain
on painful
region
200
MU_4034_4044_ENG_Rev05_092009
*********
************
26-28 mA
30-60 min.
3-4 x a day
cont. 8-10
hours a day
13
TENSMED II 4044
TENSMED IV 4034
Types of Electrodes
Conductive silicon: The silicon electrode utilization requires the use of
conductive gel and securing tapes.
Adherents: The application of this type of electrode is performed
directly on the skin, so the conductive gel and securing tapes are not
required.
Electrode Positioning
It is essential to position the electrodes as correctly as possible to obtain
the desired results.
There are many possibilities of placing the electrodes. The most common
are:
1. Alternate
The channels are placed alternately when the stimulus is linear, in order to
ensure a higher paresthesia distribution in the painful region.
2. Bilateral
The electrodes are placed in both sides of an articulation or region;
3. Contralateral
When there are no conditions to stimulate an end or either side of the body,
the stimulus of the same nerve can be contralateral.
The contralateral stimulus does not present the same efficiency as the
ipsilateral stimulus, but in cases without normal stimulus conditions, it
should be used.
4. Cross
This is the case when the stimulus occurs with more than one channel, then
crosses the painful region, thus concentrating the current perception on the
painful region.
5. Distal
At least one electrode is placed near the painful region in order to ensure
the parenthesia perception.
6. Linear
It involves the proximal and distal placement, as in sites referring to painrelated trigger points or roots.
7. Segmentally related myotonia
MU_4034_4044_ENG_Rev05_092009
14
TENSMED II 4044
TENSMED IV 4034
When the stimulation is intolerable at the pain site, the electrodes should be
placed in distant muscular groups, but stimulated by the same marrow
levels as in the painful region.
8. Proximal
The electrodes are placed above the lesion level. This method is efficient for
peripheral nerve lesions, marrow lesions and phantom limb pains.
9. High cervical region
The electrodes are placed behind the ear and immediately over the mastoid
process.
10. Remote
The electrodes are places in regions segmentally related or not to the
painful area. A remote site may be located proximally, distally or
contralaterally to the painful region. A strong stimulation is usually used in
these remote areas.
11. Not related sites
Good results can be obtained through the stimulation of:
superficial regions of sciatic, median and ulnar nerves;
column bottom and top ends;
transcranial and high cervical regions.
12. Transcranial
Stimulation in both temporal cavities. The exact point is 2.5 cm before and
above the ear.
Electrode application
1. Connect the electrode to the output cable of the channel that you may
want to use;
2. If this is a silicon electrode, apply a thin gel film on the electrode and
place it on the application site, use adhesive tape (micro pore or similar)
to secure the electrode. If this is an adherent electrode, remove it from
the protection and place it on the application site.
The illustrations below show the electrode placement diagrams for some
application types:
1. Median nerve irritation (lower part) caused by carpus tunnel
compression
2. Lumbar region pain
3. Brachial plexus lesion with anesthesia below the elbow (C5T1)
MU_4034_4044_ENG_Rev05_092009
15
TENSMED II 4044
TENSMED IV 4034
4. Pain in the lower part of the back, with L5 root pain in the left leg
5&6
7.
8.
TENSMED II 4044
TENSMED IV 4034
9.
10.
11.
12.
Post-hepatic neuralgia
Obstetric application of TENS for the pain control during delivery
Hypersensitive scar on the right knee
Neck pain
Controls
A) TENSMED II 4044
Increment / Changes
Field
Moves Field to
Right
Moves Field to
Left
Decrement /
Changes Field
MU_4034_4044_ENG_Rev05_092009
16
MU_4034_4044_ENG_Rev05_092009
17
TENSMED II 4044
TENSMED IV 4034
1. UP Key
2. DOWN Key
3. LEFT Key
4. RIGHT Key
TENSMED II 4044
TENSMED IV 4034
5. START Key
6. STOP Key
Control Functions
7. CH 1 and CH 2 Intensity control for channels 1 and 2 of Tensmed II
4044.
1. UP Key
3. LEFT Key
Allows navigation through parameters to the left: MODE, Fr Hz, P uS
and TIMER.
4. RIGHT Key
Allows navigation through parameters to the right: TIMER, P uS, Fr Hz
and MODE.
5. START Key
Enables the outputs, allowing intensity values to be incremented and
decremented.
Figura 02.
MU_4034_4044_ENG_Rev05_092009
18
6. STOP Key
Interrupts the application, placing output intensities at zero, and
stops the TIMER.
7. Channel 1 intensity control: Key increments channel 1 intensity. Key
reduces channel 1 intensity.
MU_4034_4044_ENG_Rev05_092009
19
TENSMED II 4044
TENSMED IV 4034
8. Channel 2 intensity control: Key increments channel 2 intensity. Key
reduces channel 2 intensity.
TENSMED II 4044
TENSMED IV 4034
Mode
Fr Hz
P uS Timer
Values of Parameters:
1.
2.
3.
4.
Fr Hz
P uS Timer
VIF Mode:
Mode
Fr Hz
P uS Timer
Fr Hz
VLP Mode:
Mode
Fr Hz
P uS Timer
P uS Timer
VLF Mode:
Mode
Fr Hz
Fr Hz
P uS Timer
P uS Timer
Mode
Fr Hz
P uS Timer
20
MU_4034_4044_ENG_Rev05_092009
21
TENSMED II 4044
TENSMED IV 4034
TENSMED II 4044
TENSMED IV 4034
Mode
Fr Hz
P uS Timer
Fr Hz
P uS Timer
Fr Hz
P uS Timer
Fr Hz
P uS Timer
Increment / Changes
Field
Fr Hz
B) TENSMED IV 4034
This value varies from person to person, as each patient has particular
sensitivity and tissue impedance characteristics, as well as other factors
that may influence the intensity sensation.
Moves Field to
Right
P uS Timer
10. Connect the cables of the electrodes from the channels to be used to
the electrodes on the patient. (Figure 02 Page20)
11. To start the treatment, press START. The Timer will start flashing,
indicating the time counting.
MU_4034_4044_ENG_Rev05_092009
22
Moves Field to
Left
Decrement /
Changes Field
MU_4034_4044_ENG_Rev05_092009
23
TENSMED II 4044
TENSMED IV 4034
1. UP Key
2. DOWN Key
3. LEFT Key
4. RIGHT Key
TENSMED II 4044
TENSMED IV 4034
5. START Key
6. STOP Key
Control Functions
7. CH 1, CH 2, CH 3 e CH4 Intensity control for channels 1, 2, 3 and 4
of Tensmed IV 4034
1. UP Key
Figura 03.
MU_4034_4044_ENG_Rev05_092009
24
MU_4034_4044_ENG_Rev05_092009
25
TENSMED II 4044
TENSMED IV 4034
TENSMED II 4044
TENSMED IV 4034
Fr Hz
P uS Timer
Values of Parameters:
1.
2.
3.
4.
Fr Hz
P uS Timer
Mode
Fr Hz
P uS Timer
VIF Mode:
Fr Hz
VLP Mode:
Mode
Fr Hz
P uS Timer
P uS Timer
VLF Mode:
Mode
Fr Hz
Fr Hz
P uS Timer
P uS Timer
MU_4034_4044_ENG_Rev05_092009
26
MU_4034_4044_ENG_Rev05_092009
27
TENSMED II 4044
TENSMED IV 4034
4. Use or to select the Frequency (Fr Hz), as illustrated below:
Mode
Fr Hz
P uS Timer
Fr Hz
P uS Timer
Fr Hz
TENSMED II 4044
TENSMED IV 4034
P uS Timer
Fr Hz
P uS Timer
10. Connect the cables of the electrodes from the channels to be used to
the electrodes on the patient.
11. To start the treatment, press START. The Timer will start flashing,
indicating the time counting.
12. Use the control keys of channels CH 1, CH 2, CH 3 or CH 4 to
increase or decrease the stimulation intensity.
Note: The Current intensity in the patient circuit should be very
comfortable. Ask the patient to report the stimulation sensation in order
to adjust the ideal intensity value.
This value varies from person to person, as each patient has particular
sensitivity and tissue impedance characteristics, as well as other factors
that may influence the intensity sensation.
Fr Hz
P uS Timer
Fr Hz
P uS Timer
Indications
MU_4034_4044_ENG_Rev05_092009
28
Acute or chronic pain processes (minimizing the pain until its cause is
safely identified):
Lumbar and cervical pains
Lumbar and sciatic pains, trigeminal neuralgias
Brachial pains
Surgery injury pains
MU_4034_4044_ENG_Rev05_092009
29
TENSMED II 4044
TENSMED IV 4034
Contraindications
So far, no contraindications have been reported concerning TENS
utilization. However, the following applications should be avoided:
Patients with Cardiac or Brain Pacemaker;
Patients with Heart Diseases;
Patients with epilepsy;
Lumbar and abdominal regions in patients in the three first gestation
months;
Region over carotid breasts.
Not diagnosticated pain.
Note: TENS should be applied only in case of diagnosed pains; otherwise,
a pathological symptom of the body may be hidden.
MU_4034_4044_ENG_Rev05_092009
30
TENSMED II 4044
TENSMED IV 4034
Special care with adherent or silicon electrodes
For improved durability of the electrodes:
When using silicon electrodes, always clean the plug contacts, avoiding
residues that obstruct electrical contacts.
After using silicon electrodes, wash them with running water and dry
them. Store them in a fresh and dry place.
After using adherent electrodes, remove them from the electrode cable
carefully, moist them with water and store them in the envelope in a
fresh place.
Precaution Instructions
Corrective maintenance
Problems
Solutions
MU_4034_4044_ENG_Rev05_092009
31
TENSMED II 4044
TENSMED IV 4034
Nothing happens when the keys
are pressed.
Patients says the stimulation
sensation is greater in one
electrode than in the other.
Contact
assistance.
the
authorized
TENSMED II 4044
TENSMED IV 4034
- Type of protection against electrical shocks:
class II
- Protection level against electrical shocks of the applied part:
F type
- Protection level against harmful water penetration:
IPX0
- Disinfection methods:
see preventive maintenance
- Safety degree of application in the presence of anesthetic
mixture inflammable with air, oxygen or nitrous oxide:
not applicable
- Operation mode:
continuous
----------------------------------------------------------------------------------------------------
CONTINUOUS mode
Frequency
Pulse duration
BURST mode
Modulation
Frequency
Pulse duration
VIF mode
Frequency
: 5 to 170 Hz 1%
Frequency Modulation
: 25% in 6 seconds
Pulse Duration
: 70 to 370 s 1 %
Pulse Duration Modulation : 25% in 6 seconds
VLP mode
Frequency
: 1 to 200 Hz 1%
Pulse duration
: 70 to 370 s 1 %
Pulse Duration Modulation : 25% in 6 seconds
VIF mode
Frequency
: 5 to 170 Hz 1%
Frequency Modulation
: 25% in 6 seconds
Pulse Duration
: 50 to 400 s 1 %
Safety and protection class : Class II - applied part BF type
acc. to NBR IEC 60601-1 :1994 + amend
1:1997, NBR IEC 60601-1-2:2006 and NBR
IEC 60601-2-10:2002
TM
UMDNS
Classification
13-782
: 2 Hz 1%
: 100Hz 1%
: 50 s to 400 s 1 %
Technical Data
Specifications:
Power supply
Maximum consumption
Fuse
Operating frequency
Dimension
(WxHxD) cm
Weight
Channels Tensmed IV 4034
Channels Tensmed II 4044
Pulse form
Rectangular
Maximum intensity per channel
Digital timer
: 1 to 200 Hz 1 %
: 50 s to 400 s 20 %
: AM-10314290033
------------------------------------------------------------------------------------------------------Classification according to NBR IEC 60601.1 and NBR IEC 60601.2.10 rules:
MU_4034_4044_ENG_Rev05_092009
32
MU_4034_4044_ENG_Rev05_092009
33
TENSMED II 4044
TENSMED IV 4034
Acessories
Important Notes:
TENSMED IV 4054
Silicone electrodes 3 x 5 cm
Electrode cables
Yellow
Green
Blue
purple
2-Pole Power Cable
Users Manual
Contact Gel 200ml
Code 04033
Code 14635G
Code 09852G
Code 14644G
Code 14634G
Code 17394G
Code 17813G
Code 7000/200
TENSMED II 4052
Silicone electrodes 3 x 5 cm
Electrode cables
Green
Blue
2-Pole Power Cable
Users Manual
Contact Gel 200ml
Code 04033
Code 09852G
Code 14644G
Code 17394G
Code 17813G
Code 7000/200
MU_4034_4044_ENG_Rev05_092009
Class B
Harmonic Emission
IEC 61000-3-2
Class A
Voltage Floating /
Flicker Emission
IEC 61000-3-3
According to
Applicable Norms:
TENSMED II 4044
TENSMED IV 4034
34
35
TENSMED II 4044
TENSMED IV 4034
Electrostatic
discharge
IEC 61000-42
6 kV contact
8 kV air
Immunity
tests
Test level of
IEC 60601
Fast
transients /
Blasts
IEC 61000-44
2 kV power
supply line
1 kV signal
input
and
output line
Surge
IEC 61000-45
1
kV
differential
mode
2
kV
common mode
1
kV
differential
mode
2
kV
common
mode
TENSMED II 4044
TENSMED IV 4034
Voltage
failures, short
interruptions
and voltage
variations in
power supply.
IEC 61000-411
Magnetic
fields of utility
frequencies
(50/60 Hz)
IEC 61000-48
<5% Ut
(>95%
Ut
reduction)
For 0.5 cycle
<5% Ut
(>95%
Ut
reduction)
For 0.5 cycle
40% Ut
(60%
Ut
reduction)
For 5 cycles
40% Ut
(60%
Ut
reduction)
For 5 cycles
70% Ut
(30%
Ut
reduction)
For 25 cycles
70% Ut
(30%
Ut
reduction)
For 25 cycles
<5% Ut
(>95%
reduction)
For 5 s
<5% Ut
(>95%
reduction)
For 5 s
Ut
3 A/m
3 A/m
Ut
The magnetic fields of
utility
frequencies
should be levels of
typical
hospital
or
commercial
environment.
Note: Ut is the utility voltage C.A before the test level application.
MANUFACTURERS DECLARATION AND INSTRUCTION
ELECTROMAGNETIC IMMUNITY
FESMED should be used in the electromagnetic environment described as
follows. FESMED purchaser or operator should be aware that the device
operation is being done in such environment.
Immunity
tests
Conducted
RF
MU_4034_4044_ENG_Rev05_092009
36
Test level
of
IEC 60601
3 Vrms
150 kHz to
Compliance
level
3V
MU_4034_4044_ENG_Rev05_092009
Electromagnetic
environment - instructions
Portable and mobile devices of
RF communications should not
37
IEC 610004-6
Irradiated
RF
IEC 610004-3
80 MHz
3 V/m
80 MHz to
2.5 GHz
3 V/m
TENSMED II 4044
TENSMED IV 4034
TENSMED II 4044
TENSMED IV 4034
should be applied.
NOTE 2: This procedure may not be applicable to all situations. The
electromagnet propagation is affected by absorption and reflection of
structures, objects and people.
a. The intensity of fields generated by fixed transmitters, such as
telephone radio-base (mobile/wireless) and land mobile radio
stations, amateur radio stations and AM, FM and TV
radiobroadcast stations cannot be theoretically identified with
precision. In order to evaluate the electromagnetic environment
caused by fixed RF transmitters, a study on the site
electromagnetic field should be taken into account. If the field
intensity measured at the site where FESMED is used exceeds the
compliance level above, FESMED should be checked for normal
operation. If abnormal performance is observed, additional
measures should be taken, such as FESMED reorientation or
reallocation;
b. For any value above the frequency scale of 150 kHz to 80 MHz, the
field intensity should be less than 3 V/m.
Distances recommended between portable and mobile RF
communications devices and FESMED
FESMED should be used in electromagnetic environment where RF
disturbances are controlled. FESMED purchaser or operator can help
prevent electromagnetic interferences by keeping the minimum distance
between portable and mobile (transmitter) RF communications devices and
FESMED, as recommended below, according to the maximum output
power of the communications equipment.
d = 1,17. P
MHz
80 MHz to 800
d = 2,3. P
800 MHz to
2.5 GHz
Where P is the max. output
power of the transmitter in
watts (W), according to the
transmitter manufacturer, and d
is the recommended distance
in meters (m).
The field generated by fixed RF
transmitters, as determined
through
an
on-site
a
electromagnetic field study ,
should be lower than the
compliance level in each
b
frequency range .
Interferences may occur in the
neighboring
area
of
the
equipment with the following
symbol:
NOTE 1: within the of 80 MHz and 800 MHz, the highest range frequency
MU_4034_4044_ENG_Rev05_092009
38
Declared value of
max. output power
of the transmitter
(W)
150 kHz to 80
MHz
80 MHz to 800
MHz
d = 1,17 P
d = 1,17 P
d = 2,3 P
0.01
0.1
1
10
100
11.70 cm
37.00 cm
1.17 m
3.70 m
11.70 m
11.70 cm
37.00 cm
1.17 m
3.70 m
11.70 m
23.00 cm
72.70 cm
2.30 m
7.27 m
23.00 m
MU_4034_4044_ENG_Rev05_092009
39
TENSMED II 4044
TENSMED IV 4034
For transmitters with declared value of max. output power not listed above,
the recommended distance (d in meters) may be determined through the
equation applicable to the transmitter frequency, where P is the max. output
power of the transmitter in watts (W), according to the transmitter
manufacturer.
NOTE 1: between 80 MHz and 800 MHz: the highest frequency distance
should be applied.
NOTE 2: this procedure may be applied to all situations. The electromagnet
propagation is affected by absorption and reflection of structures, objects
and people.
Final Considerations
The continuous product quality improvement has been Carcis policy. Carci
reserves the right to make changes in the project and specifications, as well
as add and improve its products, with no resulting obligation to install them
in already manufactured products.
The text, illustrations and specifications contained in this manual are based
on information that was available on the printing occasion.
All rights reserved.
This manual cannot be reproduced, fully or partially, without the
authorization in writing by Carci.
Manufacturers Data
CARCI Indstria e Comrcio de Aparelhos Cirrgicos e Ortopdicos Ltda.
CNPJ 61.461.034/0001-78
I.E. : 110.182.450.113
Rua lvares Fagundes, 359 So Paulo SP Brasil 04338-000
Tel.: (0XX11) 3346 2100
e-mail : carci@carci.com.br
web site : www.carci.com.br
Carci Registration at the Department of Health: MS-1.03.142-9
For Technical Assistance:
Departamento de Assistncia Tcnica
Rua lvares Fagundes, 359 So Paulo SP Brasil 04338-000
Tel.: (0XX11) 5621 7024 / 5622 8205
e-mail : sat@carci.com.br
Technician in Charge:
Orlando Orlandi Melo de Carvalho - CREA 5061377287/D
MU_4034_4044_ENG_Rev05_092009
40
TENSMED II 4044
TENSMED IV 4034
REFERENCES
1. Bertrand Sr. Method of determining optimal stimulation sites for
transcutaneous electrical nerve stimulation. Physical Therapy 64:924928, 1984.
2. Bohm E. Transcutaneous electrical nerve stimulation in chronic pain after
peripheral nerve injury. Acta Neurochir (Wien) 40:277-283, 1978.
3. Fried T, Johnson R, McCracken W: Transcutaneous electrical nerve
stimulation: Its role in the control of Chronic pain. Arch Phys Med Rehab
65:228-231, 1984.
4. Goldner Jl, Nashold Bs Jr, Hendrix PC: Peripheral nerve electrical
stimulation. Clin Orthopedic 163:33-41,1982.
5. Hanson P, Ekblon A: Transcutaneous electrical nerve stimulation (TENS)
as compared to placebo TENS for the Relief of acute oro-facial pain.
Pain 15:157-165, 1983.
6. Harvie KW: A major Advantage in the control postoperative Knee pain.
Orthopedics 2:1-2, 1979.
7. Mannheimer C, Lun S, Carisson C-A The effect of transcutaneous
electrical nerve stimulation (TENS) on joint pain in patients with
rheumatoid arthritis, Scand J Rheumatol 7:13-16, 1978.
8. Miler Jones CHM: Forum: Transcutaneous nerve stimulation in labor.
Anesthesia 35:372-375, 1980.
9. Pike PHM: Transcutaneous electrical stimulation: Its use in management
of postoperative pain. Anesthesia 33: 165-171, 1978.
10. McClean, D, Owen, H Gray C and Wallace D (1986). TENS postoperative analgesia a plasma beta-endorphin concentration,
Proceedings of Anesthetic Research Society, British Journal of
Anesthesia, 58,121P-122P.
11. Eriksson, M B E, Sjolund, B H and Nielzen, S (1979), Long-Term
results of peripheral conditioning stimulation as an analgesia measure
in chronic pain, Pain, 6, 335-347.
12. Wolf, C J (1984), Transcutaneous and implanted nerve stimulation, in
Wall, Pd and Melzak, R (eds) The Textbook of Pain, Churchill Living
stone, Edinburgh, chapter 3d1, pages 679-690.
13. Wolf SL, Gersh MR., Rao VR: Examination of electrode Placements
and stimulating parameters in treating chronic pain with conventional
transcutaneous electrical nerve stimulation (TENS). Pain 11:847,1981.
MU_4034_4044_ENG_Rev05_092009
41
TENSMED II 4044
TENSMED IV 4034
14. Moore DE, Blacker HM: How effective is TENS for Chronic Pain. Am J
Nurs 83:1175-1177,1983.
15. Schomburg FL, Carter-Baker SA: Transcutaneous electrical nerve
stimulation for postolaparotomy pain. Physiotherapy 63:188:193, 1983.
16. Taylor Ag, West Ba Simon B, et al: How effective is TENS for acute
pain. Am J Nurs 83:1171-1174, 1983.
17. Solomon RA, Viernistein MC, Long DM: Reduction of postoperative
pain and narcotic use by transcutaneous electrical nerve stimulation.
Surgery 87:142-146.
18. Sodipo Joa, Adedeji SA, Olumide O: Postoperative pain relief by TENS.
Am J Chin Med 8:190-194, 1980.
19. Riley JE: The impact of TENS on the post-cesarean patient. Journal of
Obstetrics, Gynecology, and Neonatal Nursing 11:325-329, 1982.
20. Erkola R Pikkola P, Kanto J: Transcutaneous nerve stimulation for pain
relief during labor: A controlled Study. Ann Chir Gynaecol 69:273-277,
1980.
21. Jones M C M H: Transcutaneous nerve stimulation in labor. Anesthesia
35:372-375,1980.
22. Satisteban AJ: The role of Physical agents in the treatment of spine
pain. Clin Orthorp 179:24-30,1983.
23. Melzak R, Vetere P, Finch L: Transcutaneous electrical nerve
stimulation for low back pain: A comparison of TENS and Massage for
pain and range motion. Physiotherapy 63:489-493, 1983.
24. Taylor P, Hallett M, Flaherty L: Treatment of osteoarthitis of the knee
with transcutaneous never stimulation. Pain 11:233-240, 1981.
25. Winnem MF, Amundsen T: Treatment of phantom limb pain with
transcutaneous electrical nerve stimulation. Pain 12:299-300,1982.
26. Kahn J: Transcutaneous electrical nerve stimulation for no united
fractures: A clinical report. Physiotherapy 62:950-844, 1982.
27. Gersh MR, Wolf SL, Rao VR: Evaluation of transcutaneous electrical
nerve stimulation for pain relief in peripheral neuropathy: A clinical
documentation. Physiotherapy 60:48-52, 1980.
MU_4034_4044_ENG_Rev05_092009
42
TENSMED II 4044
TENSMED IV 4034
General literature
MU_4034_4044_ENG_Rev05_092009
43